STD診断の市場規模、シェア、動向分析レポート：製品別、用途別、技術別、検査部位別、地域別、セグメント予測、2024年～2030年

STD診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のSTD診断市場規模は、2024年から2030年にかけてCAGR 7.18％で拡大し、2030年には163億6,000万米ドルに達する見込みです。

性感染症（STD）の疾病負担の増加や、若年層の認知度を高め定期的なスクリーニングを奨励する政府・非営利団体の取り組みが、市場成長を増大させる主な要因です。WHOのデータによると、梅毒、淋病、クラミジア、トリコモナスなどの新規感染者は、世界で毎年約3億7,400万人に上ります。

次世代HIV検査キットやマルチプレックスPCR製品などの先進的な製品の開発・商品化により、医師は様々なSTIをタイムリーに診断・鑑別し、適切な治療を行うことができます。韓国を拠点とする診断会社Seegene, Inc.は、様々な原因物質を検出するAllplex、Anyplex、Seeplex製品の幅広いポートフォリオを提供しています。例えば、Allplex STI/BV Panel Assayは1回の検査で28の原因物質を区別できます。2022年4月、Seegene, Inc.はAllplex HPV HR Detectionの開発を発表しました。

Allplex HPV HR Detectionは、世界で初めて商業化された「3 Ct」PCRアッセイです。Seegene社は、この技術をSTI、尿路感染症（UTI）、呼吸器ウイルス（RV）アッセイを含む製品チェーン全体に応用することに注力しています。この戦略的な技術的進歩は、性感染症（STD）診断薬業界における同社のシェアを拡大する上で、さらなる優位性をもたらすものと期待されます。

HIV国家戦略計画は、2030年までに米国におけるヒト免疫不全ウイルスの流行をなくすためのロードマップです。2021年から2025年まで続くこのHIV計画は、同国にとって3回目の5カ年HIV国家計画であり、2030年までにヒト免疫不全ウイルスの新規感染を90％半減させるという10年目標を掲げています。さらに、「ウイルス性肝炎国家戦略計画」では、性行為によって感染するB型肝炎とC型肝炎に焦点を当てています。2021年1月、米国保健社会福祉省（HHS）は、米国におけるウイルス性肝炎がもたらす予防可能で実質的な公衆衛生の脅威に対処するための全国戦略を発表しました。政府の有益な行動は、STD診断産業の拡大に有利な雰囲気を作り出しています。

各社は、新製品の開発や規制当局の承認を支援し、STD診断の製品ポートフォリオを強化する戦略的な取り組みを行っています。例えば、2020年8月、DiaSorin, Inc.はLIAISON XL MUREX anti-HBeの導入について米国FDAから510（k）承認を取得しました。これはHBV感染の診断に使用されます。このイムノアッセイ製品は化学発光の原理で作動します。

性病診断市場レポートハイライト

• 2023年、消耗品セグメントは最大の市場シェアを占め、STD診断のための高い検査率や複数のアッセイの商品化により、予測期間中もその地位を維持すると予測されます。
• 技術別では、ハイスループットPCR技術の利用が増加していること、HIV検査にNAAT検査が推奨されていることから、分子診断薬分野が予測期間中に最も速いCAGRで成長すると推定されます。複数の病原体を同時に検出するマルチプレックスPCR検査の開発も、STD診断業界の成長に寄与すると予想されます。
• 用途別では、HIV検査分野が2023年にSTD診断業界を支配すると予想されます。これは、HIVの高い罹患率、分子検査に対する製品承認の増加、政府の有利な取り組みなどの要因によるものです。
• アジア太平洋諸国は、STD検査率の上昇、可処分所得の増加、発展途上国におけるSTD有病率の高さなどから、予測期間中に最も速い成長が見込まれます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 STD診断市場の変数、動向、および範囲

• 普及と成長の見通しのマッピング
• ユーザー視点の分析
• 規制と償還の枠組み
• 市場促進要因分析
  • 世界的に増大する性感染症による疾病負担
  • STD診断における技術の進歩
  • 早期診断と治療を奨励する政府の取り組み
• 市場抑制要因分析
  • 性感染症の予防接種の対象範囲
• COVID-19の影響分析
• SWOT分析、要因別（政治・法律、経済、技術）
• 業界分析- ポーターのファイブフォース分析

第4章 STD診断市場：セグメント分析、製品別、2018年～2030年

• STD診断市場：製品変動分析
• 機器とサービス
• 消耗品
• ソフトウェア

第5章 STD診断市場：用途別セグメント分析、2018年～2030年

• STD診断市場：用途の変動分析
• Ct/NG検査
• 梅毒検査
• HSVテスト
• HPV検査
• HIV検査
• ウレアプラズマとマイコプラズマの検査
• トリコモナス検査
• VZVテスト
• ゴノロヒートテスト
• その他の試験

第6章 STD診断市場：技術別セグメント分析、2018-2030年

• STD診断市場：技術変動分析
• 分子診断学
• 免疫測定法
• その他

第7章 STD診断市場：セグメント分析、検査場所別、2018～2030年

• STD診断市場：検査の場所の変動分析
• 臨床検査
• ポイントオブケア検査

第8章 STD診断市場：セグメント分析、地域別、2018年～2030年

• STD診断市場：地域別の見通し
• 北米
• 欧州
• アジア太平洋地域
• ラテンアメリカ
• 中東・アフリカ

第9章 STD診断市場：競争分析

• 主要市場参入企業による最近の動向と影響分析
• 企業の分類
• ベンダー情勢
• 主要企業の市場シェア分析、2022年
• 公開会社
• 非公開会社
• 企業プロファイル
  • BD
  • F. HOFFMANN-LA ROCHE LTD.
  • HOLOGIC INC. (GEN PROBE)
  • ABBOTT
  • CEPHEID (DANAHER)
  • QIAGEN
  • ORASURE TECHNOLOGIES, INC
  • BIO-RAD LABORATORIES, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • SEEGENE INC.
  • DIASORIN S.P.A

第10章 結論

List of Tables

• Table 1 List of secondary sources
• Table 2 List of Abbreviations
• Table 3 List of key distributors
• Table 4 List of other companies
• Table 5 List of key emerging companies/technology disruptors/innovators
• Table 6 Global STD Diagnostics Market, By Region, 2018 - 2030 (USD Million)
• Table 7 Global STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 8 Global STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 9 Global STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 10 Global STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 11 North America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 12 North America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 13 North America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 14 North America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 15 North America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 16 U.S. STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 17 U.S. STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 18 U.S. STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 19 U.S. STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 20 Canada STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 21 Canada STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 22 Canada STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 23 Canada STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 24 Europe STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 25 Europe STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 26 Europe STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 27 Europe STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 28 Europe STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 29 UK STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 30 UK STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 31 UK STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 32 UK STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 33 Germany STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 34 Germany STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 35 Germany STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 36 Germany STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 37 France STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 38 France STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 39 France STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 40 France STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 41 Spain STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 42 Spain STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 43 Spain STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 44 Spain STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 45 Italy STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 46 Italy STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 47 Italy STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 48 Italy STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 49 Denmark STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 50 Denmark STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 51 Denmark STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 52 Denmark STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 53 Sweden STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 54 Sweden STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 55 Sweden STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 56 Sweden STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 57 Norway STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 58 Norway STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 59 Norway STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 60 Norway STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 66 Japan STD Diagnostics Market, By Product Type, 2018 - 2030 (USD Million)
• Table 67 Japan STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 68 Japan STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 69 Japan STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 70 China STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 71 China STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 72 China STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 73 China STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 74 India STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 75 India STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 76 India STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 77 India STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 78 Australia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 79 Australia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 80 Australia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 81 Australia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 82 South Korea STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 83 South Korea STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 84 South Korea STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 85 South Korea STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 86 Thailand STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 87 Thailand STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 88 Thailand STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 89 Thailand STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 90 Latin America STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 91 Latin America STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 92 Latin America STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 93 Latin America STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 94 Latin America STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 95 Brazil STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 96 Brazil STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 97 Brazil STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 98 Brazil STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 99 Mexico STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 100 Mexico STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 101 Mexico STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 102 Mexico STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 103 Argentina STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 104 Argentina STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 105 Argentina STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 106 Argentina STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 107 MEA STD Diagnostics Market, By Country, 2018 - 2030 (USD Million)
• Table 108 MEA STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 109 MEA STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 110 MEA STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 111 MEA STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 112 South Africa STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 113 South Africa STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 114 South Africa STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 115 South Africa STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 116 Saudi Arabia STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 117 Saudi Arabia STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 118 Saudi Arabia STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 119 Saudi Arabia STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 120 UAE STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 121 UAE STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 122 UAE STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 123 UAE STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)
• Table 124 Kuwait STD Diagnostics Market, By Product, 2018 - 2030 (USD Million)
• Table 125 Kuwait STD Diagnostics Market, By Technology, 2018 - 2030 (USD Million)
• Table 126 Kuwait STD Diagnostics Market, By Application, 2018 - 2030 (USD Million)
• Table 127 Kuwait STD Diagnostics Market, By Location of Testing, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 STD Diagnostics Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value-chain-based sizing & forecasting
• Fig. 7 QFD modeling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 Market outlook (2023)
• Fig. 10 Penetration and growth prospect mapping
• Fig. 11 User perspective analysis
• Fig. 12 STD Diagnostics Market driver impact
• Fig. 13 Prevalence of STIs by WHO regions (in 2023)
• Fig. 14 STD Diagnostics Market restraint impact
• Fig. 15 SWOT Analysis, By Factor (Political & Legal, Economic, and Technological)
• Fig. 16 Porter's Five Forces Analysis
• Fig. 17 STD diagnostics product outlook: Key takeaways
• Fig. 18 STD Diagnostics Market: Product movement analysis
• Fig. 19 Instruments and Services market, 2018 - 2030 (USD Million)
• Fig. 20 Consumables market, 2018 - 2030 (USD Million)
• Fig. 21 Software market, 2018 - 2030 (USD Million)
• Fig. 22 STD diagnostics application outlook: Key takeaways
• Fig. 23 STD Diagnostics Market: Application movement analysis
• Fig. 24 CT/NG testing market, 2018 - 2030 (USD Million)
• Fig. 25 Prevalence (%) of syphilis by WHO regions
• Fig. 26 Syphilis testing market, 2018 - 2030 (USD Million)
• Fig. 27 Syphilis PCR testing market, 2018 - 2030 (USD Million)
• Fig. 28 Syphilis non-PCR testing market, 2018 - 2030 (USD Million)
• Fig. 29 HSV testing market, 2018 - 2030 (USD Million)
• Fig. 30 Herpes Simplex Virus PCR testing market, 2018 - 2030 (USD Million)
• Fig. 31 Herpes Simplex Virus non-PCR testing market, 2018 - 2030 (USD Million)
• Fig. 32 HPV testing market, 2018 - 2030 (USD Million)
• Fig. 33 Prevalence (%) of HIV by WHO regions
• Fig. 34 HIV testing market, 2018 - 2030 (USD Million)
• Fig. 35 Ureaplasma & mycoplasma testing market, 2018 - 2030 (USD Million)
• Fig. 36 Trichomonas testing market, 2018 - 2030 (USD Million)
• Fig. 37 VZV testing market, 2018 - 2030 (USD Million)
• Fig. 38 VZV PCR testing market, 2018 - 2030 (USD Million)
• Fig. 39 VZV non-PCR testing market, 2018 - 2030 (USD Million)
• Fig. 40 Other testing market, 2018 - 2030 (USD Million)
• Fig. 41 STD diagnostics technology outlook: Key takeaways
• Fig. 42 STD Diagnostics Market: Technology movement analysis
• Fig. 43 Molecular Diagnostics market, 2018 - 2030 (USD Million)
• Fig. 44 Immunoassay market, 2018 - 2030 (USD Million)
• Fig. 45 Others market, 2018 - 2030 (USD Million)
• Fig. 46 STD diagnostics location of testing outlook: Key takeaways
• Fig. 47 STD Diagnostics Market: Location of testing movement analysis
• Fig. 48 Laboratory testing market, 2018 - 2030 (USD Million)
• Fig. 49 Commercial/private labs market, 2018 - 2030 (USD Million)
• Fig. 50 Public health labs market, 2018 - 2030 (USD Million)
• Fig. 51 Point of care testing market, 2018 - 2030 (USD Million)
• Fig. 52 Regional outlook, 2023 & 2030
• Fig. 53 Regional marketplace: Key takeaways
• Fig. 54 North America SWOT
• Fig. 55 North America STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 56 U.S. Country Dynamics
• Fig. 57 U.S. Target Disease Prevalence
• Fig. 58 U.S. STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 59 Canada Country Dynamics
• Fig. 60 Canada Target Disease Prevalence
• Fig. 61 Canada STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 62 Europe SWOT
• Fig. 63 Europe STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 64 UK Country Dynamics
• Fig. 65 UK Target Disease Prevalence
• Fig. 66 UK STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 67 Germany Country Dynamics
• Fig. 68 GermanyTarget Disease Prevalence
• Fig. 69 Germany STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 70 France Country Dynamics
• Fig. 71 France Target Disease Prevalence
• Fig. 72 France STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 73 Spain Country Dynamics
• Fig. 74 Spain Target Disease Prevalence
• Fig. 75 Spain STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 76 Italy Country Dynamics
• Fig. 77 Italy Target Disease Prevalence
• Fig. 78 Italy STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 79 Denmark Country Dynamics
• Fig. 80 Denmark Target Disease Prevalence
• Fig. 81 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 82 Sweden Country Dynamics
• Fig. 83 Sweden Target Disease Prevalence
• Fig. 84 Sweden STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 85 Denmark Country Dynamics
• Fig. 86 Denmark Target Disease Prevalence
• Fig. 87 Denmark STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 88 Asia Pacific SWOT
• Fig. 89 Asia Pacific STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 90 Japan Country Dynamics
• Fig. 91 Japan Target Disease Prevalence
• Fig. 92 Japan STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 93 China Country Dynamics
• Fig. 94 China Target Disease Prevalence
• Fig. 95 China STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 96 India Country Dynamics
• Fig. 97 India Target Disease Prevalence
• Fig. 98 India STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 99 Australia Country Dynamics
• Fig. 100 Australia Target Disease Prevalence
• Fig. 101 Australia STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 102 South Korea Country Dynamics
• Fig. 103 South Korea Target Disease Prevalence
• Fig. 104 South Korea STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 105 Thailand Country Dynamics
• Fig. 106 Thailand Target Disease Prevalence
• Fig. 107 Thailand STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 108 Latin America SWOT
• Fig. 109 Latin America STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 110 Brazil Country Dynamics
• Fig. 111 Brazil Target Disease Prevalence
• Fig. 112 Brazil STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 113 Mexico Country Dynamics
• Fig. 114 Mexico Target Disease Prevalence
• Fig. 115 Mexico STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 116 Argentina Country Dynamics
• Fig. 117 Argentina Target Disease Prevalence
• Fig. 118 Argentina STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 119 Middle East & Africa SWOT
• Fig. 120 Middle East & Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 121 South Africa Country Dynamics
• Fig. 122 South Africa Target Disease Prevalence
• Fig. 123 South Africa STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 124 Saudi Arabia Country Dynamics
• Fig. 125 Saudi Arabia Target Disease Prevalence
• Fig. 126 Saudi Arabia STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 127 UAE Country Dynamics
• Fig. 128 UAE Target Disease Prevalence
• Fig. 129 UAE STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 130 Kuwait Country Dynamics
• Fig. 131 Kuwait Target Disease Prevalence
• Fig. 132 Kuwait STD Diagnostics Market, 2018 - 2030 (USD Million)
• Fig. 133 Heat map analysis
• Fig. 134 Company market share analysis (2023)
• Fig. 135 Company market position analysis (2023)
• Fig. 136 Company market position analysis (2023)
• Fig. 137 Market differentiators
• Fig. 138 Regional Network Map 

STD Diagnostics Market Growth & Trends:

The global STD diagnostics market size is expected to reach USD 16.36 billion by 2030, expanding at a CAGR of 7.18% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing disease burden of Sexually Transmitted Disease (STD) and efforts by government & non-profit organizations to increase awareness and encourage regular screenings among the younger population are the key factors augmenting the market growth. According to WHO data, around 374 million new cases of syphilis, gonorrhea, chlamydia, and trichomoniasis are recorded every year globally.

Development and commercialization of advanced products, such as next-generation HIV testing kits and multiplex PCR products, enable physicians to timely diagnose & distinguish a range of STIs and provide appropriate treatment. Seegene, Inc., a South Korea-based diagnostic company, provides a wide portfolio of Allplex, Anyplex, and Seeplex products that detect various causative agents. For instance, Allplex STI/BV Panel Assay can distinguish 28 causative agents in a single test. In April 2022, Seegene, Inc. announced the development of Allplex HPV HR Detection.

Allplex HPV HR Detection is the world's first commercialized '3 Ct' PCR assay. Seegene is focusing to apply this technology to its entire product chain, including STI, Urinary Tract Infection (UTI), and Respiratory Virus (RV) assays. This strategic technological advancement is expected to provide an additional advantage to the company that can help increase its share in the Sexually Transmitted Disease (STD) diagnostics industry.

The HIV National Strategic Plan is a roadmap for eliminating the human immunodeficiency virus pandemic in the U.S. by 2030. The HIV Plan, which will run from 2021 to 2025, is the country's third five-year national HIV plan in a row, with a 10-year goal of halving new human immunodeficiency virus infections by 90% by 2030. Furthermore, the Viral Hepatitis National Strategic Plan focuses on hepatitis B and C, which are sexually transmitted. In January 2021, the US Department of Health and Human Services (HHS) released a nationwide strategy to address the preventable, substantial public health threats posed by viral hepatitis in the United States. The government's beneficial actions create a favorable atmosphere for the expansion of the STD diagnostics industry.

Companies are engaging in strategic initiatives that aid in the development of new products, and regulatory approvals as well as enhance their STD diagnostics product portfolio. For instance, in August 2020, DiaSorin, Inc. received 510 (k) approval from U.S. FDA for introducing LIAISON XL MUREX anti-HBe. It is used for the diagnosis of HBV infection. This immunoassay product works on the principle of chemiluminescence.

STD Diagnostics Market Report Highlights:

• In 2023, the consumables segment accounted for the largest market share and is anticipated to maintain its position over the forecast period owing to high testing rates for the diagnosis of STDs and the commercialization of several assays
• Based on technology, the molecular diagnostics segment is estimated to grow at the fastest CAGR during the forecast period owing to the increasing use of high-throughput PCR technology and the recommendation of NAAT tests for HIV testing. The development of multiplex PCR tests for the simultaneous detection of multiple pathogens is also expected to contribute to the STD diagnostics industry's growth
• Based on application, the HIV testing segment is expected to dominate the STD diagnostics industry in 2023, due to factors such as the high incidence rate of the disease, increasing product approvals for molecular tests, and favorable government initiatives
• Asia Pacific region is anticipated to experience the fastest growth over the forecast period due to an increase in testing rates for STDS, a rise in disposable income, and high disease prevalence of STD in developing countries

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market Segmentation and Scope
  • 1.1.1 Segment Scope
  • 1.1.2 Regional Scope
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Research Methodology
• 1.3 Information Procurement
  • 1.3.1 Purchased Database:
  • 1.3.2 Gvr's Internal Database
  • 1.3.3 Secondary Sources
  • 1.3.4 Primary Research
  • 1.3.5 Details Of Primary Research
• 1.4 Information Or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
    • 1.6.1.1 Approach: Commodity Flow Approach
• 1.7 Research Assumptions
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations
• 1.10 Objectives
  • 1.10.1 Objective 1
  • 1.10.2 Objective 2
  • 1.10.3 Objective 3
  • 1.10.4 Objective 4

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Product And Application Snapshot
• 2.3 Technology And Location Of Testing Snapshot
• 2.4 Competitive Snapshot

Chapter 3 STD Diagnostics Market Variables, Trends, And Scope

• 3.1 Penetration And Growth Prospect Mapping
• 3.2 User Perspective Analysis
• 3.3 Regulatory And Reimbursement Framework
• 3.4 Market Driver Analysis
  • 3.4.1 Growing Global Disease Burden Of STDs
  • 3.4.2 Technological Advancements In STD Diagnostics
  • 3.4.3 Government Initiatives Encouraging Early Diagnosis And Treatment
• 3.5 Market Restraint Analysis
  • 3.5.1 Vaccination Coverage For STDs
• 3.6 Covid-19 Impact Analysis
• 3.7 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
• 3.8 Industry Analysis - Porter's

Chapter 4 STD Diagnostics Market: Segment Analysis, By Product, 2018 - 2030 (USD Million)

• 4.1 STD Diagnostics Market: Product Movement Analysis
• 4.2 Instruments And Services
  • 4.2.1 Instruments And Services Market, 2018 - 2030 (USD Million)
• 4.3 Consumables
  • 4.3.1 Consumables Market, 2018 - 2030 (USD Million)
• 4.4 Software
  • 4.4.1 Software Market, 2018 - 2030 (USD Million)

Chapter 5 STD Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 STD Diagnostics Market: Application Movement Analysis
• 5.2 Ct/Ng Testing
  • 5.2.1 Ct/Ng Testing Market, 2018 - 2030 (USD Million)
• 5.3 Syphilis Testing
  • 5.3.1 Syphilis Testing Market, 2018 - 2030 (USD Million)
  • 5.3.2 Syphilis Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.3.3 Syphilis Non-Pcr Testing Market, 2018 - 2030 (USD Million)
• 5.4 Hsv Testing
  • 5.4.1 Hsv Testing Market, 2018 - 2030 (USD Million)
  • 5.4.2 Herpes Simplex Virus Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.4.3 Herpes Simplex Virus Non-Pcr Testing Market, 2018 - 2030 (USD Million)
• 5.5 Hpv Testing
  • 5.5.1 Hpv Testing Market, 2018 - 2030 (USD Million)
• 5.6 Hiv Testing
  • 5.6.1 Human Immunodeficiency Virus Testing Market, 2018 - 2030 (USD Million)
• 5.7 Ureaplasma & Mycoplasma Testing
  • 5.7.1 Ureaplasma & Mycoplasma Testing Market, 2018 - 2030 (USD Million)
• 5.8 Trichomonas Testing
  • 5.8.1 Trichomonas Testing Market, 2018 - 2030 (USD Million)
• 5.9 Vzv Testing
  • 5.9.1 Vzv Testing Market, 2018 - 2030 (USD Million)
  • 5.9.2 Vzv Pcr Testing Market, 2018 - 2030 (USD Million)
  • 5.9.3 Vzv Non-Pcr Testing Market, 2018 - 2030 (USD Million)
• 5.10 Gonorrheatesting
  • 5.10.1 Gonorrhea Testing Market, 2018 - 2030 (USD Million)
• 5.11 Other Testing
  • 5.11.1 Other Testing Market, 2018 - 2030 (USD Million)

Chapter 6 STD Diagnostics Market: Segment Analysis, By Technology, 2018-2030 (USD Million)

• 6.1 STD Diagnostics Market: Technology Movement Analysis
• 6.2 Molecular Diagnostics
  • 6.2.1 Molecular Diagnostics Market, 2018 - 2030 (USD Million)
• 6.3 Immunoassay
  • 6.3.1 Immunoassay Market, 2018 - 2030 (USD Million)
• 6.4 Others
  • 6.4.1 Others Market, 2018 - 2030 (USD Million)

Chapter 7 STD Diagnostics Market: Segment Analysis, By Location Of Testing, 2018 - 2030 (USD Million)

• 7.1 STD Diagnostics Market: Location Of Testing Movement Analysis
• 7.2 Laboratory Testing
  • 7.2.1 Laboratory Testing Market, 2018 - 2030 (USD Million)
  • 7.2.2 Commercial/Private Labs
    • 7.2.2.1 Commercial/Private Labs Market, 2018 - 2030 (USD Million)
  • 7.2.3 Public Health Labs
    • 7.2.3.1 Public Health Labs Market, 2018 - 2030 (USD Million)
• 7.3 Point Of Care Testing
  • 7.3.1 Point Of Care Testing Market, 2018 - 2030 (USD Million)

Chapter 8 STD Diagnostics Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

• 8.1 STD Diagnostics Market: Regional Outlook
• 8.2 North America
  • 8.2.1 North America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2 U.S.
    • 8.2.2.1 Key Country Dynamics
    • 8.2.2.2 U.S. STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2.3 Target Disease: Cancer Incidence
    • 8.2.2.4 Market And Competitive Scenario
    • 8.2.2.5 Regulatory Framework
    • 8.2.2.6 Reimbursement Scenario
  • 8.2.3 Canada
    • 8.2.3.1 Key Country Dynamics
    • 8.2.3.2 Canada STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3.3 Target Disease: Cancer Incidence
    • 8.2.3.4 Market And Competitive Scenario
    • 8.2.3.5 Regulatory Framework
    • 8.2.3.6 Reimbursement Scenario
• 8.3 Europe
  • 8.3.1 Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2 UK
    • 8.3.2.1 Key Country Dynamics
    • 8.3.2.2 Uk STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2.3 Target Disease Prevalence
    • 8.3.2.4 Market And Competitive Scenario
    • 8.3.2.5 Regulatory Framework
    • 8.3.2.6 Reimbursement Scenario
  • 8.3.3 Germany
    • 8.3.3.1 Key Country Dynamics
    • 8.3.3.2 Germany STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3.3 Target Disease Prevalence
    • 8.3.3.4 Market And Competitive Scenario
    • 8.3.3.5 Regulatory Framework
    • 8.3.3.6 Reimbursement Scenario
  • 8.3.4 France
    • 8.3.4.1 Key Country Dynamics
    • 8.3.4.2 France STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4.3 Target Disease Prevalence
    • 8.3.4.4 Market And Competitive Scenario
    • 8.3.4.5 Regulatory Framework
    • 8.3.4.6 Reimbursement Scenario
  • 8.3.5 Spain
    • 8.3.5.1 Key Country Dynamics
    • 8.3.5.2 Spain STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5.3 Target Disease Prevalence
    • 8.3.5.4 Market And Competitive Scenario
    • 8.3.5.5 Regulatory Framework
    • 8.3.5.6 Reimbursement Scenario
  • 8.3.6 Italy
    • 8.3.6.1 Key Country Dynamics
    • 8.3.6.2 Italy STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6.3 Target Disease Prevalence
    • 8.3.6.4 Market And Competitive Scenario
    • 8.3.6.5 Regulatory Framework
    • 8.3.6.6 Reimbursement Scenario
  • 8.3.7 Denmark
    • 8.3.7.1 Key Country Dynamics
    • 8.3.7.2 Denmark STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7.3 Target Disease Prevalence
    • 8.3.7.4 Market And Competitive Scenario
    • 8.3.7.5 Regulatory Framework
    • 8.3.7.6 Reimbursement Scenario
  • 8.3.8 Sweden
    • 8.3.8.1 Key Country Dynamics
    • 8.3.8.2 Sweden STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8.3 Target Disease Prevalence
    • 8.3.8.4 Market And Competitive Scenario
    • 8.3.8.5 Regulatory Framework
    • 8.3.8.6 Reimbursement Scenario
  • 8.3.9 Norway
    • 8.3.9.1 Key Country Dynamics
    • 8.3.9.2 Norway STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9.3 Target Disease Prevalence
    • 8.3.9.4 Market And Competitive Scenario
    • 8.3.9.5 Regulatory Framework
    • 8.3.9.6 Reimbursement Scenario
  • 8.3.10 Rest Of Europe STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.4 Asia Pacific
  • 8.4.1 Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2 Japan
    • 8.4.2.1 Key Country Dynamics
    • 8.4.2.2 Japan STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2.3 Target Disease Prevalence
    • 8.4.2.4 Market And Competitive Scenario
    • 8.4.2.5 Regulatory Framework
    • 8.4.2.6 Reimbursement Scenario
  • 8.4.3 China
    • 8.4.3.1 Key Country Dynamics
    • 8.4.3.2 China STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3.3 Target Disease Prevalence
    • 8.4.3.4 Market And Competitive Scenario
    • 8.4.3.5 Regulatory Framework
    • 8.4.3.6 Reimbursement Scenario
  • 8.4.4 India
    • 8.4.4.1 Key Country Dynamics
    • 8.4.4.2 India STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4.3 Target Disease Prevalence
    • 8.4.4.4 Market And Competitive Scenario
    • 8.4.4.5 Regulatory Framework
    • 8.4.4.6 Reimbursement Scenario
  • 8.4.5 Australia
    • 8.4.5.1 Key Country Dynamics
    • 8.4.5.2 Australia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5.3 Target Disease Prevalence
    • 8.4.5.4 Market And Competitive Scenario
    • 8.4.5.5 Regulatory Framework
    • 8.4.5.6 Reimbursement Scenario
  • 8.4.6 Thailand
    • 8.4.6.1 Key Country Dynamics
    • 8.4.6.2 Thailand STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6.3 Target Disease Prevalence
    • 8.4.6.4 Market And Competitive Scenario
    • 8.4.6.5 Regulatory Framework
    • 8.4.6.6 Reimbursement Scenario
  • 8.4.7 South Korea
    • 8.4.7.1 Key Country Dynamics
    • 8.4.7.2 South Korea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7.3 Target Disease Prevalence
    • 8.4.7.4 Market And Competitive Scenario
    • 8.4.7.5 Regulatory Framework
    • 8.4.7.6 Reimbursement Scenario
  • 8.4.8 Rest Of Asia Pacific STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5 Latin America
  • 8.5.1 Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2 Brazil
    • 8.5.2.1 Key Country Dynamics
    • 8.5.2.2 Brazil STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2.3 Target Disease Prevalence
    • 8.5.2.4 Competitive Scenario
    • 8.5.2.5 Regulatory Framework
    • 8.5.2.6 Reimbursement Scenario
  • 8.5.3 Mexico
    • 8.5.3.1 Key Country Dynamics
    • 8.5.3.2 Mexico STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3.3 Target Disease Prevalence
    • 8.5.3.4 Competitive Scenario
    • 8.5.3.5 Regulatory Framework
    • 8.5.3.6 Reimbursement Scenario
  • 8.5.4 Argentina
    • 8.5.4.1 Key Country Dynamics
    • 8.5.4.2 Argentina STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4.3 Target Disease Prevalence
    • 8.5.4.4 Competitive Scenario
    • 8.5.4.5 Regulatory Framework
    • 8.5.4.6 Reimbursement Scenario
  • 8.5.5 Rest Of Latin America STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6 Mea
  • 8.6.1 Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2 South Africa
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 South Africa STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2.3 Target Disease Prevalence
    • 8.6.2.4 Competitive Scenario
    • 8.6.2.5 Regulatory Framework
    • 8.6.2.6 Reimbursement Scenario
  • 8.6.3 Saudi Arabia
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Saudi Arabia STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3.3 Target Disease Prevalence
    • 8.6.3.4 Competitive Scenario
    • 8.6.3.5 Regulatory Framework
    • 8.6.3.6 Reimbursement Scenario
  • 8.6.4 UAE
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Uae STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4.3 Target Disease Prevalence
    • 8.6.4.4 Competitive Scenario
    • 8.6.4.5 Regulatory Framework
    • 8.6.4.6 Reimbursement Scenario
  • 8.6.5 Kuwait
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Kuwait STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5.3 Target Disease Prevalence
    • 8.6.5.4 Competitive Scenario
    • 8.6.5.5 Regulatory Framework
    • 8.6.5.6 Reimbursement Scenario
  • 8.6.6 Rest Of Mea STD Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9 STD Diagnostics Market: Competitive Analysis

• 9.1 Recent Developments And Impact Analysis, By Key Market Participants
  • 9.1.1 New Product Launches
  • 9.1.2 Mergers And Acquisitions
  • 9.1.3 Partnerships And Strategic Collaboration
  • 9.1.4 Conferences And Campaigns
• 9.2 Company Categorization
  • 9.2.1 Innovators
  • 9.2.2 Market Leaders
  • 9.2.3 Heat Map Analysis
• 9.3 Vendor Landscape
  • 9.3.1 List Of Key Distributors And Channel Partners
  • 9.3.2 Key Customers
• 9.4 Key Company Market Share Analysis, 2022
• 9.5 Public Companies
  • 9.5.1 Company Market Position Analysis
  • 9.5.2 Competitive Dashboard Analysis
    • 9.5.2.1 Market Differentiators
• 9.6 Private Companies
  • 9.6.1 List Of Key Emerging Companies
  • 9.6.2 Regional Network Map
• 9.7 Company Profiles
  • 9.7.1 BD
    • 9.7.1.1 Company Overview
    • 9.7.1.2 Financial Performance
    • 9.7.1.3 Product benchmarking
    • 9.7.1.4 Strategic initiatives
  • 9.7.2 F. HOFFMANN-LA ROCHE LTD.
    • 9.7.2.1 Company overview
    • 9.7.2.2 Financial Performance
    • 9.7.2.3 Product benchmarking
    • 9.7.2.4 Strategic initiatives
  • 9.7.3 HOLOGIC INC. (GEN PROBE)
    • 9.7.3.1 Company Overview
    • 9.7.3.2 Financial Performance
    • 9.7.3.3 Product Benchmarking
    • 9.7.3.4 Strategic Initiatives
  • 9.7.4 ABBOTT
    • 9.7.4.1 Company Overview
    • 9.7.4.2 Financial Performance
    • 9.7.4.3 Product Benchmarking
    • 9.7.4.4 Strategic Initiatives
  • 9.7.5 CEPHEID (DANAHER)
    • 9.7.5.1 Company Overview
    • 9.7.5.2 Financial Performance
    • 9.7.5.3 Product Benchmarking
    • 9.7.5.4 Strategic Initiatives
  • 9.7.6 QIAGEN
    • 9.7.6.1 Company Overview
    • 9.7.6.2 Financial Performance
    • 9.7.6.3 Product Benchmarking
    • 9.7.6.4 Strategic Initiatives
  • 9.7.7 ORASURE TECHNOLOGIES, INC
    • 9.7.7.1 Company Overview
    • 9.7.7.2 Financial Performance
    • 9.7.7.3 Product Benchmarking
    • 9.7.7.4 Strategic Initiatives
  • 9.7.8 BIO-RAD LABORATORIES, INC.
    • 9.7.8.1 Company Overview
    • 9.7.8.2 Financial Performance
    • 9.7.8.3 Product Benchmarking
    • 9.7.8.4 Strategic Initiatives
  • 9.7.9 BIOMERIEUX SA
    • 9.7.9.1 Company overview
    • 9.7.9.2 Financial Performance
    • 9.7.9.3 Product benchmarking
    • 9.7.9.4 Strategic initiatives
  • 9.7.10 THERMO FISHER SCIENTIFIC, INC.
    • 9.7.10.1 Company overview
    • 9.7.10.2 Financial performance
    • 9.7.10.3 Product benchmarking
    • 9.7.10.4 Strategic initiatives
  • 9.7.11 SEEGENE INC.
    • 9.7.11.1 Company overview
    • 9.7.11.2 Financial performance
    • 9.7.11.3 Product benchmarking
    • 9.7.11.4 Strategic initiatives
  • 9.7.12 DIASORIN S.P.A
    • 9.7.12.1 Company overview
    • 9.7.12.2 Financial performance
    • 9.7.12.3 Product benchmarking
    • 9.7.12.4 Strategic initiatives

Chapter 10 Conclusion